
    
      As second objectives, the study aims to:

        -  Evaluate the GFR decline in patients who had an underlying chronic kidney disease.

        -  Evaluate factors associated with a persistent decreased GFR at day-90.

        -  Characterization the clinical and biological phenotype of chronic renal disease in these
           patients.

        -  Evaluate treatments provided to these patients according to CKD occurence.

        -  Evaluate the rate of cardiovascular and thrombo-embolic morbidity-mortality.

        -  Assess the quality of life every year for 3 years.

        -  Evaluate the medico-economic burden of CKD.
    
  